![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 30, 2004 7:37:43 PM
As to 'inclination'....how many powerful and effective superdrugs are sitting on the shelves of big Pharma, having failed the approval process due to unacceptable side effects at the last stage?
There are billions of dollars in revenue already locked and loaded, just waiting for the FDA to define the acceptance criteria.
Big Pharma may be the 'enemy' but they are both powerful and smart. The obvious benefit of drug classifiers has been obvious to the world since before the Genome project started. Why do you think the FDA is developing the guidelines.....for DNAP?
It is far more efficient for big Pharma to work their way back through their catalog of already developed drugs than it is to develop new ones from scratch.
It is OK to bet against such obvious ramifications of the developing industry, that is also your perogative....but don't bet much!
regards,
frog
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM